Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Conference Coverage

Conference Coverage
Treat-to-Target Tapering of TNFi Studied for Noninferiority in PsA, axSpA
01/03/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic...
01/03/2024
Rheumatology & Arthritis
Conference Coverage
Positive or Negative? Multimorbidity and Disease Activity in RA
12/27/2023

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
Investigators examined the association between multimorbidity in rheumatoid arthritis and its association with flares and remission in comparison to seropositivity.
Investigators examined the association between multimorbidity in rheumatoid arthritis and its association with flares and remission in comparison to seropositivity.
Investigators examined the...
12/27/2023
Rheumatology & Arthritis
Conference Coverage
Black Box Warning No Deterrent to JAKi Adherence in RA
12/27/2023

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
A retrospective cohort study found that patients with rheumatoid arthritis treated with Janus kinase inhibitors were no less adherent to their medication regimen after the addition of a black box warning by the US Food and Drug Administration
A retrospective cohort study found that patients with rheumatoid arthritis treated with Janus kinase inhibitors were no less adherent to their medication regimen after the addition of a black box warning by the US Food and Drug Administration
A retrospective cohort study...
12/27/2023
Rheumatology & Arthritis

Advertisement

Conference Coverage
Victoria Konzett, MD, on RA Flares Based on SDAI and CDAI
12/27/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.
During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.
During her presentation on...
12/27/2023
Rheumatology & Arthritis
Conference Coverage
Dr Peter Taylor on Effectiveness of Upadacitinib in RA Pain Management
12/26/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Patients with rheumatoid arthritis generally consider pain to be the highest priority domain compared to any other symptoms.
Patients with rheumatoid arthritis generally consider pain to be the highest priority domain compared to any other symptoms.
Patients with rheumatoid...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
Gregory McDermott, MD: Predictors of RA-ILD and Subtypes
12/26/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Several factors have been shown to be associated with increased risk of rheumatoid arthritis-associated lung diseases. Dr Gregory McDermott investigates.
Several factors have been shown to be associated with increased risk of rheumatoid arthritis-associated lung diseases. Dr Gregory McDermott investigates.
Several factors have been shown...
12/26/2023
Rheumatology & Arthritis

Advertisement

Conference Coverage
Breakthrough COVID-19 Infection Among RA Patients After Third Dose
12/26/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
In August 2021, the CDC recommended a third SARS-CoV-2 mRNA vaccine dose to complete the initial vaccine series for immunosuppressed patients.
In August 2021, the CDC recommended a third SARS-CoV-2 mRNA vaccine dose to complete the initial vaccine series for immunosuppressed patients.
In August 2021, the CDC...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
This or That? Rieke Alten, MD, Reviews Treatment Preferences for RA Patients
12/20/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Findings of an online survey revealed the trade-offs most acceptable among patients with rheumatoid arthritis when selecting treatments.
Findings of an online survey revealed the trade-offs most acceptable among patients with rheumatoid arthritis when selecting treatments.
Findings of an online survey...
12/20/2023
Rheumatology & Arthritis
Conference Coverage
Rheumatoid Arthritis and Long COVID—A Double Whammy
12/20/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
The increased odds of Long COVID in rheumatoid arthritis (RA)—a direct response to infection or the natural RA symptom course? Dr Kaleb Michaud explains.
The increased odds of Long COVID in rheumatoid arthritis (RA)—a direct response to infection or the natural RA symptom course? Dr Kaleb Michaud explains.
The increased odds of Long COVID...
12/20/2023
Rheumatology & Arthritis

Advertisement

Conference Coverage
Is There a Window of Opportunity in Psoriatic Arthritis?
12/13/2023

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
Early referral to rheumatologists of patients who present with symptoms of psoriatic arthritis (PsA) is associated with better clinical outcomes.
Early referral to rheumatologists of patients who present with symptoms of psoriatic arthritis (PsA) is associated with better clinical outcomes.
Early referral to...
12/13/2023
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Stay in the Know

Rheumatology & Arthritis Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

News
FDA Grants Orphan Drug Designation to Efzofitimod for Systemic Sclerosis
04/19/2022
The new immunomodulator outperformed existing antifibrotic agents in animal models.
The new immunomodulator outperformed existing antifibrotic agents in animal models.
The new immunomodulator...
04/19/2022
Rheumatology & Arthritis
doc & patient
Primary Care
Referring Patients to a Rheumatologist
05/20/2022
In this video, Monica Richey, MSN, NP, speaks about when a primary care provider should refer a patient to a rheumatologist, including how to expedite the process.
In this video, Monica Richey, MSN, NP, speaks about when a primary care provider should refer a patient to a rheumatologist, including how to expedite the process.
In this video, Monica Richey,...
05/20/2022
Rheumatology & Arthritis
News
Low-Dose Prednisolone Benefits Older Adults With RA
06/30/2011
A favorable risk-benefit balance was found for older adults with rheumatoid arthritis who received low-dose prednisolone for up to 2 years.
A favorable risk-benefit balance was found for older adults with rheumatoid arthritis who received low-dose prednisolone for up to 2 years.
A favorable risk-benefit balance...
06/30/2011
Rheumatology & Arthritis
News
Planning, Management Key to Positive Pregnancy Outcomes in axSpA
09/01/2022
An analysis of pregnancy registries showed that among women with axial spondyloarthritis who received preconception counseling and tight management, most outcomes were similar to those for the general population.
An analysis of pregnancy registries showed that among women with axial spondyloarthritis who received preconception counseling and tight management, most outcomes were similar to those for the general population.
An analysis of pregnancy...
09/01/2022
Rheumatology & Arthritis
Alexis Ogdie
Podcast
Alexis Ogdie, MD, on Adverse Effects of Methotrexate in PsA
02/28/2023
Dr Ogdie discusses her research into the differences in reactions to methotrexate and tumor necrosis factor inhibitors among patients with psoriatic arthritis and rheumatoid arthritis.
Dr Ogdie discusses her research into the differences in reactions to methotrexate and tumor necrosis factor inhibitors among patients with psoriatic arthritis and rheumatoid arthritis.
Dr Ogdie discusses her research...
02/28/2023
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use